SOLANA CO
HSDTNASDAQTrading Snapshot
- Day Range
- $280.40 β $287.44
- 52-Week Range
- $1.19 β $20.50
- Volume
- $2.11B
- Avg Volume
- $2.54B
- Shares Outstanding
- 58.4M
- Next Earnings
- Dec 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $6M
- Last Q Revenue
- $3M
- P/E Ratio
- -0.1
- P/S Ratio
- 13.7x
- EPS (TTM)
- $-2.01
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +713.6%
Why Investors Own HSDT
- βHigh-growth profile β revenue up +28.6% YoY with expanding US Equity exposure.
- βHealthy economics β 65% gross margin and 30% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SOLANA CO
HSDTAbout SOLANA CO
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates
SOLANA CO tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift HSDT price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
SOLANA CO announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.